 This is House Call for Health. The FDA recently voting against endorsing a well-known party drug to treat PTSD. Considered a major blow to psychedelic treatment advocates, a U.S. Food and Drug Administration advisory panel voted against the use of MDMA to treat post-traumatic stress disorder. The decision came after a lengthy debate on the risks and benefits of using the drug